North America At-home Chronic Disease Biomarker Testing Market Size & Outlook
Related Markets
North America at-home chronic disease biomarker testing market highlights
- The North America at-home chronic disease biomarker testing market generated a revenue of USD 2,222.9 million in 2025.
- The market is expected to grow at a CAGR of 17.5% from 2026 to 2033.
- In terms of segment, consumables & rreagents was the largest revenue generating product in 2025.
- Test Kits/Devices is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 2,222.9 million |
| Market revenue in 2033 | USD 8,055.3 million |
| Growth rate | 17.5% (CAGR from 2026 to 2033) |
| Largest segment | Consumables & rreagents |
| Fastest growing segment | Test Kits/Devices |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Test Kits/Devices, Consumables & Rreagents |
Other key industry trends
- In terms of revenue, North America region accounted for 44.1% of the global at-home chronic disease biomarker testing market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,500.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
At-home Chronic Disease Biomarker Testing Market Scope
At-home Chronic Disease Biomarker Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| FutureWell Group | View profile | 11-50 | San Antonio, Texas, United States, North America | http://futurewellgroup.com |
| NiaHealth | View profile | 11-50 | Edmonton, Alberta, Canada, North America | https://www.niahealth.co/ |
| AMR Labs | View profile | 1-10 | Dongan, Kyonggi-do, South Korea, Asia | http://www.amrlabs.co.kr |
| SiPhox Health | View profile | 11-50 | Burlington, Massachusetts, United States, North America | https://siphoxhealth.com |
| EverlyWell | View profile | 251-500 | Austin, Texas, United States, North America | https://www.everlywell.com/ |
| Hims & Hers Health Inc Ordinary Shares - Class A | View profile | 1046 | 2269 Chestnut Street, Suite 523, San Francisco, CA, United States, 94123 | https://www.forhims.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
North America at-home chronic disease biomarker testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to at-home chronic disease biomarker testing market will help companies and investors design strategic landscapes.
Consumables & rreagents was the largest segment with a revenue share of 69.31% in 2025. Horizon Databook has segmented the North America at-home chronic disease biomarker testing market based on test kits/devices, consumables & rreagents covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America at-home chronic disease biomarker testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America at-home chronic disease biomarker testing market databook
-
Our clientele includes a mix of at-home chronic disease biomarker testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America at-home chronic disease biomarker testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America at-home chronic disease biomarker testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America at-home chronic disease biomarker testing market size, by country, 2021-2033 (US$M)
North America At-home Chronic Disease Biomarker Testing Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
